You just read:

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

News provided by

Reportlinker

Dec 13, 2016, 23:25 ET